439 related articles for article (PubMed ID: 12397719)
1. Enhanced color flows in hepatic tumors.
Yang CC; Chen CH; Yeh YH
Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
[TBL] [Abstract][Full Text] [Related]
2. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of hepatic tumors by color Doppler imaging: role of the maximum velocity and the pulsatility index of the intratumoral blood flow signal.
Kudo M; Tochio H; Zhou P
Intervirology; 2004; 47(3-5):154-61. PubMed ID: 15383724
[TBL] [Abstract][Full Text] [Related]
4. Assessment of vascularity in hepatic tumors: comparison of power Doppler sonography and intraarterial CO(2)-enhanced sonography.
Chen RC; Chen WT; Tu HY; Cheng NY; Wang CK; Liao LY; Wang CS; Chen PH
AJR Am J Roentgenol; 2002 Jan; 178(1):67-73. PubMed ID: 11756089
[TBL] [Abstract][Full Text] [Related]
5. Use of hepatic tumor index on color Doppler sonography for differentiating large hepatic tumors.
Numata K; Tanaka K; Kiba T; Morimoto M; Arata S; Kondo M; Sekihara H
AJR Am J Roentgenol; 1997 Apr; 168(4):991-5. PubMed ID: 9124156
[TBL] [Abstract][Full Text] [Related]
6. Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors.
Choi BI; Kim TK; Han JK; Chung JW; Park JH; Han MC
Radiology; 1996 Jul; 200(1):55-8. PubMed ID: 8657945
[TBL] [Abstract][Full Text] [Related]
7. Hemangiomas and focal nodular hyperplasia images in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging.
Janica J; Serwatka W; Polaków J; Ustymowicz A; Łebkowska U; Kordecki K; Walecki J; Polaków P; Dobrzycki S
Med Sci Monit; 2004 Jun; 10 Suppl 3():26-31. PubMed ID: 16538195
[TBL] [Abstract][Full Text] [Related]
8. [Native and signal-enhanced power Doppler sonography for characterization of liver lesions].
Strunk H; Stuckmann G; Fröhlich E; Textor J; Wilhelm K; Hortling N; Remig J
Rofo; 1998 Apr; 168(4):344-51. PubMed ID: 9589096
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia.
Yen YH; Wang JH; Lu SN; Chen TY; Changchien CS; Chen CH; Hung CH; Lee CM
Eur J Radiol; 2006 Dec; 60(3):439-44. PubMed ID: 16916591
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced power Doppler sonography: improved detection of characteristic flow patterns in focal liver lesions.
Hosten N; Puls R; Lemke AJ; Steger W; Zendel W; Zwicker C; Felix R
J Clin Ultrasound; 1999; 27(3):107-15. PubMed ID: 10064407
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced, wide-band phase-inversion power Doppler imaging of hepatic focal nodular hyperplasia.
Janica J; Wojciech S; Dolorzycki S; Polakow J; Walecki J; Ladny JR; Laszewicz W
Hepatogastroenterology; 2004; 51(57):705-8. PubMed ID: 15143897
[TBL] [Abstract][Full Text] [Related]
12. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL
Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
14. Contrast media-enhanced power Doppler sonography for evaluation of hemangiomas and malignant tumors in the liver.
Karabacakoglu A; Karakose S; Cil AS; Kaya A
J Gastroenterol Hepatol; 2003 Jan; 18(1):92-8. PubMed ID: 12519230
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of small hepatocellular carcinoma and adenomatous hyperplasia with power Doppler sonography.
Koito K; Namieno T; Morita K
AJR Am J Roentgenol; 1998 Jan; 170(1):157-61. PubMed ID: 9423624
[TBL] [Abstract][Full Text] [Related]
16. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma.
Tanaka S; Kitamra T; Yoshioka F; Kitamura S; Yamamoto K; Ooura Y; Imaoka T
Ultrasound Med Biol; 1995; 21(2):157-60. PubMed ID: 7571125
[TBL] [Abstract][Full Text] [Related]
18. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: therapeutic experience with percutaneous ethanol injection under real-time contrast-enhanced color Doppler sonography with the contrast agent Levovist.
Shirato K; Morimoto M; Tomita N; Kokawa A; Sugimori K; Saito T; Numata K; Sekihara H; Tanaka K
J Ultrasound Med; 2002 Sep; 21(9):1015-22. PubMed ID: 12216749
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors.
Strobel D; Krodel U; Martus P; Hahn EG; Becker D
J Clin Ultrasound; 2000 Jan; 28(1):1-13. PubMed ID: 10602099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
